Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin and N-acetyl Cysteine in ITP
NCT05551624Phase 1Completed
- Sponsor
- Hospital Civil de Guadalajara
- Start
- Jul 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of atorvastatin and acetylcysteine in primary immune thrombocytopenia (ITP), sponsored by Hospital Civil de Guadalajara. Primary endpoint: Change from Baseline in Mean Serum Platelet Count at 12 months. Started Jul 2018; status: completed.
02
Drugs
atorvastatinacetylcysteine
03
Conditions
primary immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT05551624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05551624.